HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform

This article was originally published in The Pink Sheet

Executive Summary

Prestige Brands makes the deal three weeks after divesting the slower-selling Massengill douche brand and as it makes a top marketing priority of growing sales of its Monistat yeast treatment line.

You may also be interested in...



Moberg Adds DermoPlast Line With Bondholders' Blessing For More

Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.

DenTek Deal Expands Prestige Brands’ Oral Care Portfolio, OTC Focus

While overall oral care sales grow 2.4% in the 52-week period through Oct. 3, sales of the sub-category of floss picks, dental guards, interdental brushes, disposable picks, dental wax, floss threaders, dental picks and tongue cleaners grew 9%. DenTek is first in floss pick sales and second in interdental brush sales.

Prestige Brands Visits Doctors To Cure Slumping Monistat Sales

The firm in the second half of 2015 plans six initiatives to influence health care professionals on recommending Monistat for patients, CEO Matthew Mannelly says. Sales of Monistat have slid since a previous owner of the brand stopped marketing to health care professionals.

Topics

Related Companies

UsernamePublicRestriction

Register

RS123167

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel